Business Description
Akebia Therapeutics is a Massachusetts-based medical company founded in 2007 that develops and sells treatments for people living with kidney disease. Its two approved medicines help patients manage anemia and high phosphorus levels associated with chronic kidney disease, while two additional drugs are currently being tested in clinical trials for conditions including kidney injury following heart surgery and an eye disorder affecting premature newborns. The company markets its products across multiple regions through licensing partnerships with pharmaceutical firms in Japan, Asia, and other territories.
